Curetis USA is focused on delivering fast, reliable and cost-effective molecular solutions to aid in diagnosing severe infectious diseases. Now the first FDA approved molecular diagnostic panel for lower respiratory tract infections, Curetis’ Unyvero System provides clinicians with rapid and critical information for the early detection of Lower Respiratory Tract microorganisms and their associated antibiotic resistance markers.
Additional applications are in development for Invasive Joint Infections, Intra-Abdominal Infections, Blood Culture and Urinary Tract Infections.
Company’s Keywords:
molecular biology, multiplex pcr, medical devices, diagnostics, antibiotic resistance, superbugs, syndromic testing, lower respiratory infections, healthcare, microbiology, antibiotic stewardship
2
medical devices
1&1 Email Provider, Google Cloud Hosting, Outlook, Route 53, Amazon SES, Amazon AWS, Drupal, Adobe Marketing Cloud, accessiBe, Mobile Friendly, Google Tag Manager, Typekit, Vimeo, Google Font API, Bootstrap Framework, Nginx, Wistia, WordPress.org, Varnish, New Relic, Gravity Forms
2016
Your request has been submitted successfully.
Own or work here?